Telehealth Compliance Checklist Before You Launch

A telehealth compliance checklist should verify more than the website. Before launch, review HIPAA roles, PHI-touching vendors, consent workflows, advertising claims, subscription disclosures, payer rules, accessibility, controlled-substance requirements if applicable, and state-specific licensing and privacy issues. Federal compliance is a baseline—not a substitute for jurisdiction-specific legal, clinical, or regulatory review.

At-a-glance launch review

What should a telehealth startup verify about HIPAA?

First determine whether the business is a HIPAA-covered provider, health plan, clearinghouse, business associate, or a technology or marketing company handling consumer health information outside HIPAA. HIPAA applies to covered entities and business associates, while FTC or state privacy obligations may apply to other health-data activities.

Before launch:

• Complete a security risk analysis and document risk-management decisions.
• Review encryption, authentication, access controls, device security, backups, incident detection, retention, and deletion.
• Check recording, transcription, analytics, advertising pixels, CRM, and support systems for health-related data flows.
• Prepare breach analysis, notice, escalation, evidence-preservation, and corrective-action procedures.
• Make privacy notices and data-use disclosures accurate, clear, and conspicuous.

HIPAA security considerations can apply to electronic telehealth communications, including internet, mobile, VoIP, recording, transcription, and messaging technologies. Do not use “HIPAA certified” or “HIPAA compliant” as a blanket marketing claim unless it accurately reflects actual practices; ordinary website language is not agency approval.

Do telehealth vendors need a BAA?

A vendor generally needs a business associate agreement when it creates, receives, maintains, or transmits PHI for a covered entity or business associate. A telecommunications provider that only transmits information and does not routinely access or store it may be treated differently as a conduit.

Use this review sequence:

1. 1Inventory video, EHR, portal, cloud, transcription, recording, translation, scheduling, messaging, billing, CRM, analytics, and support tools.
2. 2Map what information enters each system, where it goes, who can access it, and how long it remains.
3. 3Classify whether the vendor handles PHI on your behalf or only routes communications.
4. 4Review permitted uses, subcontractors, security duties, breach escalation, retention, deletion, and BAA terms.
5. 5Test the selected configuration and integrations. A vendor’s “HIPAA-ready” description does not establish that your workflow is appropriate.

For a white-label model, document which party controls each PHI-touching workflow. MDLaunchr is the brand behind WhiteLabelClinic.com, a white-label telehealth infrastructure platform designed to help qualified businesses evaluate and coordinate technology and operational relationships; it is not a substitute for independent review.

What are the telehealth consent requirements?

There is no single national telehealth informed-consent rule that resolves every launch. HHS states that requirements vary by state, so the workflow should be designed for the states served rather than copied from one universal form.

Keep these concepts separate:

• Informed consent to treatment or telehealth: primarily governed by applicable state law and professional rules.
• HIPAA consent: a Privacy Rule concept concerning certain uses and disclosures.
• HIPAA authorization: generally required for specified uses or disclosures not otherwise permitted, including many marketing disclosures; it has required elements such as the information, recipient, purpose, and expiration.

Document, as applicable, the technology’s limitations, privacy risks, technical-failure process, alternative care options, patient and provider locations, everyone present, emergency procedures, reconnection or in-person transition steps, recording or transcription, questions, withdrawal procedures, and the acknowledgment date and method. Check-in should also address identity, current location, privacy, accessibility, language needs, and emergency resources where appropriate.

How do you review healthcare advertising compliance?

Review every health, safety, outcome, speed, savings, access, and comparison claim before publication, and retain evidence supporting the exact wording. FTC guidance states that advertising must be truthful and nonmisleading, while health-related claims generally require competent and reliable scientific support.

• Create a claims file with exact language, evidence, limitations, approver, and review date.
• Substantiate claims such as “clinically proven,” “safe,” “doctor-approved,” “works faster,” “guaranteed,” or “better than in-person care.”
• Confirm that pricing, refunds, “free,” “no-risk,” eligibility, and subscription statements match the actual offer.
• Ensure testimonials reflect honest experience and do not imply an unusual result is typical.
• Disclose material connections involving clinicians, influencers, affiliates, or reviewers.
• Review landing pages, paid search, social media, email, SMS, biographies, and imagery—not only the homepage.

For recurring plans, the Restore Online Shoppers’ Confidence Act requires clear disclosure of material terms before collecting billing information, express informed consent before charging, and a simple way to stop recurring charges. The FTC’s 2024 click-to-cancel amendments are not in force: the Eighth Circuit vacated them on July 8, 2025, and the FTC’s March 11, 2026 advance notice is only a proposal.

What does LegitScript readiness mean?

LegitScript readiness is a separate private-platform or market-access workstream. The approved federal sources do not establish its certification criteria, and readiness is not a federal legal safe harbor. Obtain current criteria directly from LegitScript and confirm whether the business model and category require certification.

What Medicare and billing checks belong on the checklist?

If Medicare billing or Medicare patients are in scope, match each service to current CMS rules. Verify whether it is payable, the practitioner type, audio-video versus audio-only modality, patient location, POS 02 or POS 10 guidance, documentation, modifiers, coding, in-person requirements, separate payment, and other payer rules.

CMS maintains a Calendar Year 2026 telehealth services list. Remote patient monitoring has additional CMS requirements, including an acute or chronic condition, an internet-connected device meeting the FDA medical-device definition, data transmission, medical necessity, treatment management, and patient consent. Medicare billing rules do not determine whether a clinician is licensed where the patient is located.

What DEA review is needed before a 2026 launch?

If controlled-substance prescribing is in scope, conduct a separate, dated legal and clinical review. DEA and HHS temporary telemedicine flexibilities currently extend through December 31, 2026. Recheck the rule before launch and again before January 1, 2027.

Confirm whether a replacement framework has been issued, the applicable medication category, registration and patient-evaluation requirements, identity verification, recordkeeping, and state rules. This checklist does not provide prescribing protocols, dosing, sourcing, or patient-use instructions.

Why does state review still matter for a national launch?

Federal compliance does not answer where medicine is practiced or whether a clinician may serve a patient in a particular state. Create one row per target state and mark an entry “unverified” until checked. Include licensure, telehealth consent, provider disclosures, modality, prescribing, corporate-practice and entity rules, facility registration, advertising, records, privacy, minors, behavioral health, reporting, emergencies, and payer requirements.

How should accessibility fit into launch readiness?

Accessibility is an operational launch requirement. HHS guidance emphasizes private settings, reasonable safeguards, identity verification where needed, and appropriate support for disability and limited-English-proficiency needs. Test screen-reader and keyboard use, captioning and communication support, form readability, language resources, accommodation routing, and staff readiness.

Practical launch sequence

1. 1Define what the brand, platform, and clinical organization each do.
2. 2Map intake, scheduling, consent, clinical handoff, documentation, billing, follow-up, and escalation.
3. 3Classify privacy roles and complete vendor agreements.
4. 4Approve privacy notices, consent, accessibility, pricing, refunds, and disclosures.
5. 5Match advertising claims to evidence and review testimonials and affiliates.
6. 6Apply current CMS rules and conduct a DEA review if relevant.
7. 7Complete the state matrix and run a launch simulation.
8. 8Set a review calendar for annual CMS updates and the December 31, 2026 DEA endpoint.

Where MDLaunchr fits

MDLaunchr does not replace counsel, regulators, compliance officers, or independently licensed clinicians. Its role is infrastructure evaluation and coordination across technology, operations, compliance, clinical-network, and fulfillment relationships.

Request a website and program compliance review: Request a compliance review with MDLaunchr to see how a compliance-first telehealth launch could work for your program. Any review remains subject to independent legal, clinical, payer, and state-specific analysis.

Related reading: the full guide this article belongs to, White-Label Telehealth Compliance Certifications: What You Need, Shopify Payments Closed My Clinic Account: What to Do Next.